Ark Clinical Research

Our COVID-19 investigational treatment trials are open to those diagnosed within the last 72 hours. Call: 562-206-2922 or Apply Today: https://www.arkclinicalresearch.com/covid-19-clinical-study to learn more. Payment may be available up to $3,650

Press release from Regeneron regarding the study we are doing: https://investor.regeneron.com//regenerons-regn-cov2-antib

https://www.newyorker.com//should-trump-have-been-given-ac

https://www.nytimes.com//covid-19-vaccine-johnson-and-john We are offering this vaccine now in Long Beach and Tustin. We have full hours on Saturday and Sunday for those who work. Please repost and send around.

Dr. Kenneth Kim's interview with KTLA for Covid-19 Treatment Trial at Ark Clinical Research.

Dr. Kenneth Kim's interview with KTLA for the Covid-19 Treatment trial at Ark Clinical Research.

Dr. Kenneth Kim was interviewed by the lead Spanish speaking news network on Univision regarding the Covid-19 treatment trial at Ark Clinical Research. Please visit https://www.arkclinicalresearch.com to learn more information. https://www.univision.com//que-efectividad-puede-tener-el-

We are launching this vaccine next week at both Long Beach and Tustin locations. Go to our website if you want to volunteer for this COVID trial. https://www.nytimes.com//covid-19-vaccine-johnson-and-john

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 showing it reduced viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19. https://www.prnewswire.com//regenerons-regn-cov2-antibody-

Ark Clinical Research is participating in the Johnson & Johnson coronavirus vaccine trial. Call us now at 562-486-3270, 562-489-9650, 562-489-9651 to join! https://www.cnn.com//johnson--johnson-coronavir/index.html